Skip to main content
Top
Published in: Journal of Infection and Chemotherapy 5/2013

01-10-2013 | Original Article

Spectrum of urogenital tuberculosis

Authors: Ekaterina Kulchavenya, Irina Zhukova, Denis Kholtobin

Published in: Journal of Infection and Chemotherapy | Issue 5/2013

Login to get access

Abstract

Urogenital tuberculosis (UGTB) plays an important role because its complications may be fatal, it significantly reduces quality of life, and it is often associated with AIDS. Diagnosis of UGTB is often delayed. We analyzed 131 case histories of UGTB patients from the years 2009–2011. Gender, age, and the clinical form and main features of the disease were taken into account. The most common form was kidney tuberculosis (74.8 %). Isolated kidney tuberculosis (KTB) more often occurs in women: 56.8 %. Patients of middle and old age more often showed the stage of cavernous KTB; younger patients had smaller forms. Among all cases, an asymptomatic course was seen in 12.2 % and, among cases of KTB, in 15.9 %. Every third patient complained of flank pain and dysuria (35.2 % and 39.8 %, respectively); 17 % presented with toxicity symptoms, 9.1 % with renal colic, and 7.9 % with gross hematuria. Mycobacterium tuberculosis (MTB) in urine was found in 31.8 % of cases in all levels of isolated KTB. UGTB has no specific symptom; even sterile pyuria occurs only in 25 %. The acute onset of tuberculous orchiepididymitis was seen in 35.7 % of patients, hemospermia in 7.1 %, and dysuria in 35.7 %. The most common complaints for prostate tuberculosis were perineal pain (31.6 %), dysuria (also 31.6 %), and hemospermia (26.3 %). MTB in prostate secretion/ejaculate was revealed in 10.5 % of this group. All urogenital tract infections should be suspected as UGTB in patients who are living in a region with a high incidence rate, who have had contact with tuberculosis infection, and who have a recurrence of the disease that is resistant to standard therapy.
Literature
1.
go back to reference Trauzzi SJ, Kay CJ, Kaufman DG, Lowe FC. Management of prostatic abscess in patients with human immunodeficiency syndrome. Urology. 1994;43:629–33.PubMedCrossRef Trauzzi SJ, Kay CJ, Kaufman DG, Lowe FC. Management of prostatic abscess in patients with human immunodeficiency syndrome. Urology. 1994;43:629–33.PubMedCrossRef
2.
go back to reference Perez S, Andrade M, Bergel P, Bracho Y, de Waard JH. A simple algorithm for the diagnosis of AIDS-associated genitourinary tuberculosis. Clin Infect Dis. 2006;42:1807–8.PubMedCrossRef Perez S, Andrade M, Bergel P, Bracho Y, de Waard JH. A simple algorithm for the diagnosis of AIDS-associated genitourinary tuberculosis. Clin Infect Dis. 2006;42:1807–8.PubMedCrossRef
4.
go back to reference Aphonin AB, Perezmanas EO, Toporkova EE, Khodakovsky EP. Tuberculous infection as sexually transmitted infection. Vestnik Poslediplomnogo Obrazovaniya. 2006;3–4:69–71. Aphonin AB, Perezmanas EO, Toporkova EE, Khodakovsky EP. Tuberculous infection as sexually transmitted infection. Vestnik Poslediplomnogo Obrazovaniya. 2006;3–4:69–71.
5.
6.
go back to reference Kulchavenya E, Kim C-S. Male genital tuberculosis. In: Naber KG, Schaeffer AJ, Heyns CF, Matsumoto T, Shoskes DA, Johanses TEB, editors. International Consultation on Urogenital Infections. Stockholm, Sweden, March 2009. European Association of Urology—International Consultation on Urological Diseases, Edition 2010. Arnhem, The Netherlands, p. 877–891. Kulchavenya E, Kim C-S. Male genital tuberculosis. In: Naber KG, Schaeffer AJ, Heyns CF, Matsumoto T, Shoskes DA, Johanses TEB, editors. International Consultation on Urogenital Infections. Stockholm, Sweden, March 2009. European Association of Urology—International Consultation on Urological Diseases, Edition 2010. Arnhem, The Netherlands, p. 877–891.
7.
go back to reference Gokce G, Kilicarslan H, Ayan S, Tas F, Akar R, Kaya K, Gultekin EY. Genitourinary tuberculosis: a review of 174 cases. Scand J Infect Dis. 2002;34:338–40.PubMedCrossRef Gokce G, Kilicarslan H, Ayan S, Tas F, Akar R, Kaya K, Gultekin EY. Genitourinary tuberculosis: a review of 174 cases. Scand J Infect Dis. 2002;34:338–40.PubMedCrossRef
8.
go back to reference Figueiredo AA, Lucon AM. Urogenital tuberculosis: update and review of 8961cases from the world literature. Rev Urol. 2008;10(3):207–217. Figueiredo AA, Lucon AM. Urogenital tuberculosis: update and review of 8961cases from the world literature. Rev Urol. 2008;10(3):207–217.
9.
go back to reference Eastwood JB, Corbishley CM, Grange JM. Tuberculosis and the kidney. J Am Soc Nephrol. 2001;12:1307–14.PubMed Eastwood JB, Corbishley CM, Grange JM. Tuberculosis and the kidney. J Am Soc Nephrol. 2001;12:1307–14.PubMed
10.
go back to reference Cahill D, Dhanji M, Williams C, Smith C, Montgomery B. Genitourinary tuberculosis in middle England: look for it or miss it! BJU Int. 2001;87:273–4.PubMedCrossRef Cahill D, Dhanji M, Williams C, Smith C, Montgomery B. Genitourinary tuberculosis in middle England: look for it or miss it! BJU Int. 2001;87:273–4.PubMedCrossRef
11.
go back to reference Rieder HL, Snider DE Jr, Cauthen GM. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis. 1990;141:347–51.PubMedCrossRef Rieder HL, Snider DE Jr, Cauthen GM. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis. 1990;141:347–51.PubMedCrossRef
12.
go back to reference Kulchavenya E. Tuberculosis of urogenital system. In: Lopatkin N, editor. Urology: National Manual. Geotar-Media: Moscow; 2009. p. 584–601. Kulchavenya E. Tuberculosis of urogenital system. In: Lopatkin N, editor. Urology: National Manual. Geotar-Media: Moscow; 2009. p. 584–601.
13.
go back to reference Figueiredo AA, Lucon AM. Urogenital tuberculosis: update and review of 8961 cases from the world literature. Rev Urol. 2008;10(3):207–217. Figueiredo AA, Lucon AM. Urogenital tuberculosis: update and review of 8961 cases from the world literature. Rev Urol. 2008;10(3):207–217.
14.
go back to reference Gonzalez O. Extrapulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis. 2003;7:1178–85.PubMed Gonzalez O. Extrapulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis. 2003;7:1178–85.PubMed
15.
go back to reference Altintepe L, Tonbul H, Ozbey I. Urinary tuberculosis: ten years’ experience. Ren Failure 2005;27(6):657–661. Altintepe L, Tonbul H, Ozbey I. Urinary tuberculosis: ten years’ experience. Ren Failure 2005;27(6):657–661.
16.
go back to reference Kulchavenya E. Some aspects of urogenital tuberculosis. Int J Nephrol Urol. 2010;2:351–60. Kulchavenya E. Some aspects of urogenital tuberculosis. Int J Nephrol Urol. 2010;2:351–60.
17.
go back to reference Kul’chavenia EV. Polychemotherapy combined with low-intensity laser therapy in treating patients with renal tuberculosis. Urologiia. 2002;2:34–7.PubMed Kul’chavenia EV. Polychemotherapy combined with low-intensity laser therapy in treating patients with renal tuberculosis. Urologiia. 2002;2:34–7.PubMed
18.
go back to reference Kulchavenya E. Masks of kidney tuberculosis. Urology. 2011;78(suppl 3A):S223. Kulchavenya E. Masks of kidney tuberculosis. Urology. 2011;78(suppl 3A):S223.
Metadata
Title
Spectrum of urogenital tuberculosis
Authors
Ekaterina Kulchavenya
Irina Zhukova
Denis Kholtobin
Publication date
01-10-2013
Publisher
Springer Japan
Published in
Journal of Infection and Chemotherapy / Issue 5/2013
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-013-0586-9

Other articles of this Issue 5/2013

Journal of Infection and Chemotherapy 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine